| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:736872 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PLAGL1 mRNA | CTD | PMID:22079256 |
| (S)-colchicine | increases expression | EXP | | 6480464 | Colchicine results in increased expression of PLAGL1 mRNA | CTD | PMID:20624997 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:736873 | 6480464 | Ethinyl Estradiol affects the expression of PLAGL1 mRNA | CTD | PMID:17555576 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:736873 | 6480464 | Fenretinide results in increased expression of PLAGL1 mRNA | CTD | PMID:16467112 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:736872 | 6480464 | decitabine results in increased expression of PLAGL1 mRNA | CTD | PMID:16367923 |
| 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of PLAGL1 mRNA | CTD | PMID:22504374 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736873 | 6480464 | Tretinoin results in increased expression of PLAGL1 mRNA | CTD | PMID:16604517 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736872 | 6480464 | Tretinoin results in increased expression of PLAGL1 mRNA | CTD | PMID:21934132 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PLAGL1 mRNA | CTD | PMID:16483693 |
| Aroclor 1254 | increases expression | ISO | RGD:736872 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of PLAGL1 mRNA | CTD | PMID:16934159 |
| C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of PLAGL1 mRNA | CTD | PMID:19167457 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of PLAGL1 promoter | CTD | PMID:22457795 |
| choline | multiple interactions | ISO | RGD:736873 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLAGL1 mRNA | CTD | PMID:20938992 |
| cobalt dichloride | increases expression | ISO | RGD:736872 | 6480464 | cobaltous chloride results in increased expression of PLAGL1 mRNA | CTD | PMID:19376846 |
| crocidolite asbestos | affects expression | ISO | RGD:736872 | 6480464 | Asbestos, Crocidolite affects the expression of PLAGL1 mRNA | CTD | PMID:17331233 |
| D-glucose | decreases expression | ISO | RGD:736873 | 6480464 | Glucose results in decreased expression of PLAGL1 mRNA | CTD | PMID:17178593 |
| diazoxide | increases expression | ISO | RGD:736873 | 6480464 | Isoproterenol results in increased expression of PLAGL1 mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | increases expression | ISO | RGD:736873 | 6480464 | Dibutyl Phthalate results in increased expression of PLAGL1 mRNA | CTD | PMID:21266533 |
| folic acid | multiple interactions | ISO | RGD:736873 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLAGL1 mRNA | CTD | PMID:20938992 |
| glucose | decreases expression | ISO | RGD:736873 | 6480464 | Glucose results in decreased expression of PLAGL1 mRNA | CTD | PMID:17178593 |
| isoprenaline | increases expression | ISO | RGD:736873 | 6480464 | Isoproterenol results in increased expression of PLAGL1 mRNA | CTD | PMID:20003209 |
| kojic acid | increases expression | ISO | RGD:736872 | 6480464 | kojic acid results in increased expression of PLAGL1 mRNA | CTD | PMID:16595896 |
| L-methionine | multiple interactions | ISO | RGD:736873 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLAGL1 mRNA | CTD | PMID:20938992 |
| lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of PLAGL1 mRNA | CTD | PMID:22641619 |
| levonorgestrel | multiple interactions | ISO | RGD:736872 | 6480464 | [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PLAGL1 mRNA | CTD | PMID:19074003 |
| methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of PLAGL1 mRNA | CTD | PMID:22504374 |
| mitoxantrone | affects response to substance | ISO | RGD:736872 | 6480464 | PLAGL1 protein affects the susceptibility to Mitoxantrone | CTD | PMID:16217747 |
| nickel dichloride | decreases expression | ISO | RGD:736873 | 6480464 | nickel chloride results in decreased expression of PLAGL1 mRNA | CTD | PMID:12839937 |
| nickel sulfate | decreases expression | ISO | RGD:736873 | 6480464 | nickel sulfate results in decreased expression of PLAGL1 mRNA | CTD | PMID:16166746 |
| paracetamol | affects expression | ISO | RGD:736873 | 6480464 | Acetaminophen affects the expression of PLAGL1 mRNA | CTD | PMID:17562736 |
| pirinixic acid | decreases expression | ISO | RGD:736873 | 6480464 | pirinixic acid results in decreased expression of PLAGL1 mRNA | CTD | PMID:16985257 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of PLAGL1 mRNA | CTD | PMID:12832660 |
| quercetin | increases expression | ISO | RGD:736872 | 6480464 | Quercetin results in increased expression of PLAGL1 mRNA | CTD | PMID:21632981 |
| riboflavin | affects expression | ISO | RGD:736872 | 6480464 | Riboflavin affects the expression of PLAGL1 | CTD | PMID:16109485 |
| tamoxifen | affects expression | ISO | RGD:736873 | 6480464 | Tamoxifen affects the expression of PLAGL1 mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:736872 | 6480464 | tert-Butylhydroperoxide results in increased expression of PLAGL1 mRNA | CTD | PMID:15336504 |
| tetrachloromethane | affects expression | ISO | RGD:736873 | 6480464 | Carbon Tetrachloride affects the expression of PLAGL1 mRNA | CTD | PMID:17484886 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of PLAGL1 mRNA | CTD | PMID:16239168 |
| valproic acid | increases expression | ISO | RGD:736872 | 6480464 | Valproic Acid results in increased expression of PLAGL1 mRNA | CTD | PMID:19101580 |
| vincaleukoblastine | increases expression | EXP | | 6480464 | Vinblastine results in increased expression of PLAGL1 mRNA | CTD | PMID:20624997 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of PLAGL1 mRNA | CTD | PMID:19111725 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of PLAGL1 mRNA | CTD | PMID:19111725 |